U.S., March 27 -- ClinicalTrials.gov registry received information related to the study (NCT06895291) titled 'Whole Body MRI in Oncology' on March 19.
Brief Summary: Multicenter, observational, prospective, study. All patients will be treated and monitored according to the local clinical practice. No additional procedures/patient visits in comparison with the usual clinical practice are planned for the study.
Study Start Date: Oct. 26, 2023
Study Type: OBSERVATIONAL
Condition:
Lymphoma
Advanced Prostate Cancer
Advanced Breast Cancer
Monoclonal Gammopathy of Undetermined Significance
Smoldering Multiple Myeloma
Multiple Myeloma
Intervention:
DIAGNOSTIC_TEST: Whole Body-Magnetic Resonance Imaging (WB-MRI)
This is a non-pharmacological...